Mechanistically, while cancer cells can contain an abundance of pro-apoptotic Bcl-2 proteins, the amplification of anti-apoptotic Bcl-2 proteins can lead to BH3-only proteins being competitively depleted [83,84]. The gene discussed is BCL2; the disease is cancer.